Drug for further processing · DRUG FOR FURTHER PROCESSING
Furosemide NDC 59651-797
Furosemide 40 mg/1 · Tablet · Aurobindo Pharma Limited
Unfinished product
This listing is a drug for further processing, not a finished drug product dispensed or administered to patients. It is not normally billed.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59651-797-72 | 59651079772 | 75000 TABLET in 1 BAG (59651-797-72)Marketed from 17-JUL-25 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Generic name (nonproprietary)
- furosemide
- Active ingredients
- Furosemide — 40 mg/1
- Dosage form
- Tablet
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 59651
- Product type
- Drug for further processing
- Marketing category
- Drug for further processing
- Marketing start
- Listing expires
- Identifiers
- Product ID 59651-797_8fb9ab3f-bce1-41a0-9c4c-c9dddf3b8529SPL ID 8fb9ab3f-bce1-41a0-9c4c-c9dddf3b8529
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N459651079772followed by a unit qualifier and the quantityPackage 59651-0797-72. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 59651-797
- What is NDC 59651-797?
- 59651-797 is the product NDC for Furosemide, Furosemide 40 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Furosemide.
- What is the active ingredient?
- Furosemide.
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Furosemide?
- 211 other product NDCs are listed under this name. See all Furosemide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Furosemide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | Civica, Inc. | 72572-275 | 72572-0275-10 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4679 | 70518-4679-00 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-033 | 87441-0033-01 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Coupler LLC | 67046-0768 | 67046-0768-03 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4609 | 70518-4609-00 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Coupler LLC | 67046-1663 | 67046-1663-03 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-832 | 10135-0832-0110135-0832-1010135-0832-90 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-833 | 10135-0833-0110135-0833-1010135-0833-90 |
| Furosemide | Furosemide 80 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-834 | 10135-0834-0110135-0834-0510135-0834-90 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0164 | 63561-0164-0163561-0164-0263561-0164-09 |